These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 30964176)
21. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685 [TBL] [Abstract][Full Text] [Related]
22. [MiR-218 Targeting Bmi-1 Inhibits Proliferation of Acute Promyelocytic Leukemia Cells]. Liu JF; He P; Pan DF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):815-820. PubMed ID: 32552941 [TBL] [Abstract][Full Text] [Related]
23. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway. Wei RJ; Zhang CH; Yang WZ Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417 [TBL] [Abstract][Full Text] [Related]
24. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway. Li XD; Li XM; Gu JW; Sun XC Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427 [TBL] [Abstract][Full Text] [Related]
25. microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling. Wang L; Zhang H; Lei D Yonsei Med J; 2019 Oct; 60(10):924-934. PubMed ID: 31538427 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways. Liu Y; Song Y; Zhu X Med Sci Monit; 2017 Apr; 23():1597-1606. PubMed ID: 28365714 [TBL] [Abstract][Full Text] [Related]
27. Propofol Protects Rat Cardiomyocytes from Anthracycline-Induced Apoptosis by Regulating MicroRNA-181a Zhao H; Zhang X; Zheng Y; Li Y; Wang X; Hu N; Zhou P; Wang K Oxid Med Cell Longev; 2018; 2018():2109216. PubMed ID: 29849870 [TBL] [Abstract][Full Text] [Related]
28. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway. Huang Y; Zou Y; Lin L; Ma X; Zheng R Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139 [TBL] [Abstract][Full Text] [Related]
29. Identification of Cellular Targets of MicroRNA-181a in HepG2 Cells: A New Approach for Functional Analysis of MicroRNAs. Tan JY; Habib NA; Chuah YW; Yau YH; Geifman-Shochat S; Chen WN PLoS One; 2015; 10(4):e0123167. PubMed ID: 25901570 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis. Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014 [TBL] [Abstract][Full Text] [Related]
31. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3. Lin XM; Chen H; Zhan XL Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490 [TBL] [Abstract][Full Text] [Related]
32. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway. Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of LncRNA CRNDE aggravates kidney injury via increasing MiR-181a-5p in sepsis. Wang J; Song J; Li Y; Shao J; Xie Z; Sun K Int Immunopharmacol; 2020 Feb; 79():105933. PubMed ID: 31877497 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN. Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779 [TBL] [Abstract][Full Text] [Related]
35. [MiR-199a-5p Affects Sensitivity of Acute Myeloid Leukemia to Adriamycin by Targeting DRAM1]. Li Y; Sun Y; Miao M; Shi X; Yang W; Liu ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1096-1104. PubMed ID: 32798383 [TBL] [Abstract][Full Text] [Related]
36. Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia. Huang X; Schwind S; Santhanam R; Eisfeld AK; Chiang CL; Lankenau M; Yu B; Hoellerbauer P; Jin Y; Tarighat SS; Khalife J; Walker A; Perrotti D; Bloomfield CD; Wang H; Lee RJ; Lee LJ; Marcucci G Oncotarget; 2016 Sep; 7(37):59273-59286. PubMed ID: 27517749 [TBL] [Abstract][Full Text] [Related]
37. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity. Su PF; Song SQ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6864-6872. PubMed ID: 30402851 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression. Cui X; Zhang A; Liu J; Wu K; Chen Z; Wang Q Biochem Biophys Res Commun; 2018 Oct; 504(4):784-791. PubMed ID: 30217449 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis. Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966 [TBL] [Abstract][Full Text] [Related]
40. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway. Zhou J; Chen Q FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]